Wafaa M. Rashed

1.2k total citations
23 papers, 400 citations indexed

About

Wafaa M. Rashed is a scholar working on Public Health, Environmental and Occupational Health, Cancer Research and Genetics. According to data from OpenAlex, Wafaa M. Rashed has authored 23 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 7 papers in Cancer Research and 5 papers in Genetics. Recurrent topics in Wafaa M. Rashed's work include Acute Lymphoblastic Leukemia research (9 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Glioma Diagnosis and Treatment (4 papers). Wafaa M. Rashed is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Glioma Diagnosis and Treatment (4 papers). Wafaa M. Rashed collaborates with scholars based in Egypt, United States and Germany. Wafaa M. Rashed's co-authors include Sameera Ezzat, Mohamed A. Kandeil, Mohamed O. Mahmoud, Hala O. El‐Mesallamy, Nayera Hamdy, Nadia Μ. Hamdy, Mohamed S. Zaghloul, Marwa Matboli, Anas M. Saad and Kyrillus S. Shohdy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Wafaa M. Rashed

23 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wafaa M. Rashed Egypt 9 140 106 87 67 62 23 400
Yifeng Tao China 14 190 1.4× 105 1.0× 92 1.1× 94 1.4× 90 1.5× 37 512
Zheng Gao China 12 247 1.8× 104 1.0× 43 0.5× 17 0.3× 41 0.7× 34 453
Yuecheng Yu China 11 178 1.3× 63 0.6× 60 0.7× 59 0.9× 105 1.7× 35 394
Masako Yokoo Japan 8 103 0.7× 28 0.3× 112 1.3× 78 1.2× 102 1.6× 26 365
Ester Gonzalez‐Sanchez Spain 15 249 1.8× 90 0.8× 132 1.5× 116 1.7× 185 3.0× 25 605
Leszek Kraj Poland 12 111 0.8× 56 0.5× 24 0.3× 23 0.3× 100 1.6× 32 393
Cuiping Zhang China 11 184 1.3× 79 0.7× 45 0.5× 14 0.2× 63 1.0× 43 371
Weiping Zheng China 14 244 1.7× 200 1.9× 96 1.1× 119 1.8× 41 0.7× 62 699
Yu Dai China 10 263 1.9× 83 0.8× 70 0.8× 110 1.6× 68 1.1× 21 449
Milica Stefanović Spain 9 146 1.0× 25 0.2× 121 1.4× 96 1.4× 78 1.3× 26 454

Countries citing papers authored by Wafaa M. Rashed

Since Specialization
Citations

This map shows the geographic impact of Wafaa M. Rashed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wafaa M. Rashed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wafaa M. Rashed more than expected).

Fields of papers citing papers by Wafaa M. Rashed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wafaa M. Rashed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wafaa M. Rashed. The network helps show where Wafaa M. Rashed may publish in the future.

Co-authorship network of co-authors of Wafaa M. Rashed

This figure shows the co-authorship network connecting the top 25 collaborators of Wafaa M. Rashed. A scholar is included among the top collaborators of Wafaa M. Rashed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wafaa M. Rashed. Wafaa M. Rashed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rashed, Wafaa M., et al.. (2022). Impact of physical activity on postural stability and coordination in children with posterior fossa tumor: randomized control phase III trial. Journal of Cancer Research and Clinical Oncology. 149(9). 5637–5644. 2 indexed citations
3.
Rashed, Wafaa M., Erin L. Marcotte, & Logan G. Spector. (2022). Germline De Novo Mutations as a Cause of Childhood Cancer. JCO Precision Oncology. 6(6). e2100505–e2100505. 6 indexed citations
4.
Matboli, Marwa, et al.. (2021). mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 22(13). 6770–6770. 21 indexed citations
5.
Rashed, Wafaa M., et al.. (2020). MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines. Journal of Cancer Research and Clinical Oncology. 147(1). 167–175. 4 indexed citations
6.
Rashed, Wafaa M., Mohamed A. Kandeil, Mohamed O. Mahmoud, & Sameera Ezzat. (2020). Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. Journal of the Egyptian National Cancer Institute. 32(1). 5–5. 177 indexed citations
7.
Hammad, Mahmoud, et al.. (2020). The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries. Pediatric Hematology and Oncology. 37(3). 198–210. 8 indexed citations
8.
9.
Rashed, Wafaa M., et al.. (2019). MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations. Critical Reviews in Oncology/Hematology. 136. 70–78. 17 indexed citations
10.
Rashed, Wafaa M., et al.. (2019). Pediatric diffuse intrinsic pontine glioma: where do we stand?. Cancer and Metastasis Reviews. 38(4). 759–770. 43 indexed citations
11.
Rashed, Wafaa M., et al.. (2019). MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review. Cancer and Metastasis Reviews. 38(4). 771–782. 14 indexed citations
12.
Rezk, Mohamed, et al.. (2018). Risk of second malignancies among survivors of pediatric thyroid cancer. International Journal of Clinical Oncology. 23(4). 625–633. 8 indexed citations
13.
Rashed, Wafaa M.. (2018). C-MET as a potential target therapy toward personalized therapy in some pediatric tumors: An overview. Critical Reviews in Oncology/Hematology. 131. 7–15. 13 indexed citations
14.
Rashed, Wafaa M., et al.. (2018). Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study. Endocrine Connections. 7(10). 1040–1048. 5 indexed citations
15.
Ezzat, Sameera, Wafaa M. Rashed, M. Tevfik Dorak, et al.. (2016). Environmental, maternal, and reproductive risk factors for childhood acute lymphoblastic leukemia in Egypt: a case-control study. BMC Cancer. 16(1). 662–662. 13 indexed citations
16.
Alfaar, Ahmad Samir, Mohamed Kamal, Wafaa M. Rashed, et al.. (2016). A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. International Ophthalmology. 37(1). 111–118. 4 indexed citations
17.
Marcotte, Erin L., Thomas Thomopoulos, Jacqueline Clavel, et al.. (2015). Abstract LB-194: Cesarean delivery and risk of childhood leukemia: findings from the Childhood Leukemia International Consortium (CLIC). Cancer Research. 75(15_Supplement). LB–194. 1 indexed citations
18.
El‐Mesallamy, Hala O., Wafaa M. Rashed, Nadia Μ. Hamdy, & Nayera Hamdy. (2014). High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?. Journal of Cancer Research and Clinical Oncology. 140(8). 1359–1365. 35 indexed citations
19.
Sidhom, Iman, et al.. (2013). Outcome of risk-adapted therapy for pediatric acute lymphoblastic leukemia in Egypt.. Journal of Clinical Oncology. 31(15_suppl). 10044–10044. 4 indexed citations
20.
Zubaid, Mohammad, et al.. (2004). Differential Distribution of Risk Factors and Outcome of Acute Coronary Syndrome in Kuwait: Three Years’ Experience. Medical Principles and Practice. 13(2). 63–68. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yifeng Tao Breakdown of academic impact, for papers by Zheng Gao Breakdown of academic impact, for papers by Yuecheng Yu Breakdown of academic impact, for papers by Masako Yokoo Breakdown of academic impact, for papers by Ester Gonzalez‐Sanchez Breakdown of academic impact, for papers by Leszek Kraj Breakdown of academic impact, for papers by Cuiping Zhang Breakdown of academic impact, for papers by Weiping Zheng Breakdown of academic impact, for papers by Yu Dai Breakdown of academic impact, for papers by Milica Stefanović
Rankless by CCL
2026